International Symposium 2017

The 3rd International Symposium on IgG4-Related Diseases & Fibrosis was held in Maui, Hawaii from February 15-18, 2017. Since the first International Symposium held in Boston in 2011, the field of IgG4-RD research and clinical care has expanded substantially.

New publications about IgG4-RD and fibrosis are now appearing on a daily basis, and the extent to which knowledge of these conditions touches so many aspects of medicine have become clear.

The Third International Symposium focused on advances in understanding of the pathophysiology of IgG4-RD and the impact of this new understanding on clinical care. We have received worldwide attendance from most sub-specialties, including investigators and experts from all areas of IgG4-RD research and related disciplines.

Abstract Archive

The Abstracts for the 2017 International Symposium on IgG4-RD & Fibrosis are available on our Archive page!

View the Abstract Archives


Meeting Objectives

The objectives of the conference will be:

  • To gather an international panel of experts with an interest in IgG4-RD and its associated conditions.
  • To highlight fibrosis as a major complication of IgG4-RD and to explore the lessons for fibrosis derived from IgG4-RD and associated conditions.
  • To present the latest information about the pathophysiology, clinical and pathology features, and treatment of IgG4-RD and its associated conditions.
  • To create a forum at which new research avenues can be discussed and developed.


Meeting Themes

Some of the topics covered during this symposium were:

  • The pathology of IgG4-RD
  • The roles of individual cellular mediators of inflammation
  • Challenging individual organ manifestations
  • Pathophysiology
  • Clinical assessment
  • Treatment

Important Dates

  • Early registration deadline*: October 14, 2016

  • Pre-registration deadline*: January 20, 2017

  • Abstract submission deadline: December 31, 2016

  • Sponsorship deadline: January 15, 2017

  • Symposium: February 15-18, 2017

*Please note that registration will still be possible on-site, however the reduced rates will no longer be applicable.

2014 IgG4 Group picture



This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hawaiʻi Consortium for Continuing Medical Education and PINNACLE Marketing and Education Inc.

The Hawaiʻi Consortium for Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Hawaiʻi Consortium for Continuing Medical Education designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.